Diabetes: The 2026 ADA Standards of Care in Diabetes Embrace Technology to Support Holistic Care Laura Jaramillo, PhD News 5 Min Read For Members The 2026 update focuses on personalized, patient-centered care and integrating advanced technologies to improve diabetes management and health outcomes.
Alzheimer’s & Dementia: Semaglutide Associated with Lower Risk of Dementia in T2D Susan Kreimer News 4 Min Read For Members Findings from a database study suggest semaglutide may impact modifiable Alzheimer’s disease risk factors.
Type 2 Diabetes: Individualized Prediabetes Treatment with Safe, Affordable Medications Oladimeji Ewumi News 5 Min Read An American Diabetes Association 2025 highlight.
Type 2 Diabetes: Study Unveils Urgent Need for Inclusive Diabetes Management Oladimeji Ewumi News 4 Min Read An American Diabetes Association 2025 highlight.
Type 2 Diabetes: Language Barriers an Additional Roadblock to CGM Access Racheal Ede News 4 Min Read Language preference is a contributing factor to disparities in diabetes technology access, according to a recent study.
Obstructive Sleep Apnea: When Sleep Apnea Coincides with Chronic Disease Susan Redline, MD; Angie Drakulich, MA Interview 9 Min Read OSA can put people with cardiovascular and endocrine disorders at higher risk. Comorbidity screening is essential.
Internal Medicine: Should I weigh my patients at every visit? Alexa Mieses Malchuk, MD, MPH, FAAFP Quiz Alexa Mieses Malchuk, MD, MPH, FAAFP, answers.
Gastroenterology: GLP-1 Receptor Agonists Linked to 53% Lower Rate of Pancreatic Cancer Leah Lawrence News 3 Min Read Comparative study of people with type 2 diabetes offers another promising area for this drug class. An ACG highlight.
Diabetes: Diabetes: Is Inflammation to Blame for Increased Risks? Kimberly B. Bjugstad, PhD News 5 Min Read Recent research digs into how subtle changes in inflammation can increase risk of diabetes complications and mental health disorders.
Diabetes: What are the pros and cons of continuous glucose monitoring? Kelsey Giara, PharmD, RPh 6 Min Read As CGM technology evolves, its use is expanding beyond individuals with diabetes, with new OTC devices available. Kelsey Giara, PharmD, RPh explains.
Type 2 Diabetes: How Semaglutide is Turning Tides in Obesity, Diabetes, Kidney, and Cardiovascular Care Kelsey Giara, PharmD, RPh Commentary 7 Min Read The most recent data on semaglutide (Ozempic, Wegovy), one of the GLP-1R agonists revolutionizing the management of type 2 diabetes.
Kidney Disease: Chronic Kidney Disease Screening and Treatment Fall Short in Patients with T2D Oladimeji Ewumi News 5 Min Read Study identifies risk factors for nonconcordance with guideline-recommended CKD screening and treatment in patients with T2D.
